Stew Peters brings us another blockbuster interview with Karen Kingston, a former Pfizer employee and current analyst for the pharmaceutical and medical device industries. She comes forward with indisputable documentation that must be shared with the ENTIRE WORLD, immediately.

She says, “I read the patent to look for graphene oxide. It is not listed in the patent because it is a trade secret. Remember, Bill Gates saying that there was a trade secret?” However, the Chinese patent does list graphene oxide. She says the main reason it’s not listed in the US patent is because graphene oxide is poisonous and it’s well-known that it’s poisonous. The other reason is because it’s the main ingredient of Hydrogel, which is the liquid AI template that’s used for some of Elon Musk’s research and Bill Gates, as far as creating an interface between humans and the internet.”...
When Stew asks her about the DOJ’s pronouncement this week that COVID mandates are legal, she goes on a legal tirade, blasting Acting Assistant Attorney General Dawn Johnsen, who wrote it, saying, “Her interpretation is reckless and it has no merit. It’s just an opinion and it’s not enforceable, period.

And on top of that, what’s happened with these vaccines – these injections – is not only is the campaign and the propaganda a bunch of lies, to terrify people into getting injected, which is a violation of human rights in and of itself, on top of that, she doesn’t mention Title Code 21, which is what this memo falls under, because they violated four other sections of that title code, under Drug and Vaccine Safety. Under Section 502, it’s False and Misleading Labeling, because this thing is not a vaccine. There’s no benefit to your health when you get injected. The only thing it can do it poison, harm and kill.
“So, there’s False and Misleading labeling, it doesn’t tell you that it contains graphene oxide, Adulterated Drugs and Devices, it also violates Section 501, which, again, Adulterated Drugs and Devices is if it includes a toxin, which is the graphene oxide. It also violates Section 312.23, under Initial New Drug Applications, so if you go through an IND, you have to prove safety in animals before you move on to humans...
They also violated Section 312.42, which is Clinical Research Holds and Requests for Modification